TNC and prostate cancer: Moreover, several previous studies have shown that high expression levels of TNC along with other CAF markers in the TME correlate with poor prognosis in several malignancies, such as prostate cancer [64], breast ductal carcinoma [61], and esophageal squamous cell carcinoma [58], indicating that TNC stimulates CAFs to promote cancer aggression.